Search
Search
Close this search box.

Ireland medical cannabis survey finds broad support for reform

Over 90% of people in Ireland support further legalisation of medical cannabis according to a new survey.

Research commissioned by Irish news website The Journal.ie found widespread support for liberalising the country’s strict controls on cannabis-based treatments.

Ireland has only limited access to medical cannabis products, with decisions made on a case by case basis for a small number of conditions where it can be shown other methods have not been successful.

The trial Medical Cannabis Access Programme has some significant political support – but many voters want the government to go further and faster.

According to the survey, 93% of respondents support access to medical cannabis and just 4% of people support an outright ban.

A little over a third of respondents support recreational legalisation on top of medical.

There was a clear age divide in the responses with younger voters favouring a more liberal position – but a clear majority of over 55s still supported medical access reform.

The research was carried out between May 6-12 by marketing and polling firm Red C on behalf of the news organisation.

Responding to the survey, Nicole Lonergan of the Cork Cannabis Activist Network said: “Although this was a private survey, only open to registered Red C members, it is overwhelmingly clear that cannabis needs to be legalised in Ireland, for both adult-use and medical purposes.

“Cannabis is a wellness product first and foremost, and intent for use is down to personal responsibility of the consumer.

“It is morally wrong to deny legal access to this often life-saving natural commodity, while putting those who need it most in danger of being criminalised or consuming contaminated products obtained from an illegal market where testing and labelling isn’t required.

“This is putting approximately one fifth of the Irish population at risk each year, including children. I am calling on the Irish government to act and to legalise cannabis in Ireland.”

[activecampaign form=31]

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?